AliHussainyZaidiMD
Cardiology • New York, NYAdult Congenital Heart Disease, Echocardiography, Cardiothoracic Imaging
Director, Mount Sinai Adult Congenital Heart Disease Center Director, Academic Affairs, Childrens Heart Center, Mount Sinai Kravis Childrens Hospital Associate Professor, Medicine and Pediatrics, Icahn School of Medicine at Mount Sinai, NY
Overview of Dr. Zaidi
Dr. Ali Zaidi is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital and Mount Sinai South Nassau. He received his medical degree from Aga Khan Medical College and has been in practice 18 years. He is one of 616 doctors at The Mount Sinai Hospital and one of 84 doctors at Mount Sinai South Nassau who specialize in Cardiology. He has more than 50 publications and over 500 citings.
Office
1 Gustave L Levy Pl
New York, NY 10029
Education & Training
Ohio State University HospitalFellowship, Cardiovascular Disease, 2006 - 2011
Aga Khan Medical CollegeClass of 1999
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine/Pediatrics
Certifications & Licensure
NY State Medical License 2014 - 2025
OH State Medical License 2006 - 2015
PA State Medical License 2005 - 2006- American Board of Internal Medicine Cardiovascular Disease
- American Board of Pediatrics Pediatric Cardiology
- American Board of Internal Medicine Adult Congenital Heart Disease
Clinical Trials
- Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II Start of enrollment: 2019 Aug 01
Roles: Contact
- Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care Start of enrollment: 2022 Apr 01
Roles: Contact
Publications & Presentations
PubMed
- 75 citationsThe Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation.Ronan J. Kelly, Ali H. Zaidi, Matthew A. Smith, Ashten N. Omstead, Juliann E. Kosovec
Annals of Surgery. 2017-08-01 - 9 citationsThe effect of normal, metaplastic, and neoplastic esophageal extracellular matrix upon macrophage activation.Lindsey T. Saldin, Molly Klimak, Ryan C. Hill, Madeline C. Cramer, Luai Huleihel
Journal of Immunology and Regenerative Medicine. 2021-08-01 - 5 citationsExtracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype.Lindsey T. Saldin, Shil Patel, Li Zhang, Luai Huleihel, George S. Hussey
Tissue Engineering. Part A. 2019-04-17
Press Mentions
A 22-Year-Old's Heart Stopped for 12 Minutes. Doctors Used Hypothermia to HelpNovember 13th, 2019
AHN, Baylor Scott & White, and Johns Hopkins Researchers Confirm Effectiveness of New Immunotherapy Drug Combination for Gastroesophageal Cancer TreatmentMarch 26th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
